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Introduction 
 
John Cunningham virus (JCV) is a common pol-
yomavirus that infected about 80% of human 
population (1). JCV has some genetic similarity to 
the BK and SV40 polyomaviruses (2). These vi-
ruses are classified as Polyomaviridae family. They 
have a circular DNA molecule that packaged in 
the mini-chromosome like structure (3, 4). JC 
virus first was described by the electron micros-
copy in 1965 (5). 
Abstract 
Background: JC polyomavirus (JCV) is an epitheliotropic and neurotropic virus that identified in relationship 
with some devastating complications such as progressive multifocal leukoencephalopathy (PML) and linked to 
colorectal cancer. The aim of current study was to identify the prevalence of JCV in colorectal cancer for the 
first time in Iran.  
Methods: This retrospective case-control study was conducted by the hospitals affiliated to Iran University of 
Medical Sciences, Tehran, Iran from 2011 to 2016. Formalin-fixed paraffin-embedded (FFPE) blocks were used 
for DNA extraction by QIAamp® DNA FFPE Tissue Kit. The SYBER Green Real-time PCR assay performed 
by specific primers for JCV T-Large Ag. Melting curve analysis used for evaluation of amplification specificity. 
Positive control cloned in pTZ57R/T plasmid by Generay Biotechnology system. 
Results: Of 157 specimens 66 were colorectal cancer by the mean age (y) ± std. deviation 59.35±14.48 and 91 
healthy control by the mean age (y) ± std. deviation 57.21±14.66. All 157 specimens tested for JCV T-Large Ag 
gene by Real-time PCR method and we found that there was not any positive result although the melting analy-
sis showed specificity of positive control amplification.  
Conclusion: Low prevalence of JCV infection in Iranian CRC population confirmed by the current study re-
sults; there was not any JCV positive result in CRC and healthy control groups. Further studies by broader and 
different populations are recommended.  
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JCV transmission route is still undetermined but 
its primary infection occurred in childhood (4). 
Generally, majority of infected patients have no 
symptoms. JCV initial infection may occurs in the 
tonsils or gastrointestinal tract and then it could 
establish a latent infection there. Also, it could 
become latent in kidneys, where its replication 
causes virus shedding in the urine (2, 4). The vi-
rus could penetrate into central nervous system 
(CNS), probably by 5-HT2A serotonin receptor 
and infects oligodendrocytes and astrocytes (1, 3). 
Reactivation of the virus could trigger by serious 
immunosuppression, transplantation, and ad-
vanced HIV disease. Progressive multifocal leu-
koencephalopathy (PML) is one of serious demy-
elinating diseases associated with JCV (6, 7).  
Recently, the JCV genome detected in colorectal 
cancer (CRC) patients which may indicate the 
probable role of this virus in development of 
cancer (8, 9). Globally, CRC is the third most 
common cancer in human, and accounts for 10% 
of all cases of cancer (10). In 2012, approximately 
1.4 million new cases of CRC and 694,000 deaths 
occurred, and five-year survival rate of these pa-
tients in the United States is about 65% (10). Ear-
ly diagnosis of colonic adenoma infected with 
JCV could be helpful for using suppressive pro-
cedures in treatment strategies and to prevent its 
progression to CRC (11, 12).  
The purpose of this study was to evaluate the 
prevalence of JCV in CRC cases against a control 
group. 
 
Materials and Methods 
 
Research Population  
Current study designed as a retrospective case-
control study conducted by the hospitals affiliat-
ed to Iran University of Medical Sciences, Teh-
ran, Iran from 2011 to 2016.  
All participants diagnosed by expert pathologist 
and written consent obtained from each one. 
Ethics approved by the ethical committee of Iran 
University of Medical Sciences, Tehran, Iran via 
record number IR.IUMS.REC 1394.26669.  
Overall, 157 archived formalin-fixed paraffin-
embedded (FFPE) blocks were collected from 
patients with CRC (66 cases) and healthy subjects 
(91 cases). Age and sex matching between cases 
and control group was done. Endoscopy and co-
lonoscopy for each participants underwent by 
Fujinon machine (Fujinon, Japan). Patient’s data 
were recruited from the medical record reposito-
ry. Inclusion criteria for CRC patients were being 
sporadic cases, non-familial cancerous cases and 
written consent. Matched age and sex cases that 
underwent total colonoscopy organized as 
healthy control group and they had not any ma-
lignant lesions. Pathologic slides were stained by 
Hematoxylin and Eosin (H&E) method and re-
viewed by a sophisticated pathologist.  
 
DNA isolation 
Samples were dissected by Vibrating microtome 
(Leica VT 1000S, Leica Microsystems). The 20 
micron dissection was used for deparaffinization 
and then genomic DNA extraction by QIAamp® 
DNA FFPE Tissue Kit (QIAGEN, Hilden, 
Germany), for each sample according to manu-
facturer’s protocol. Evaluation of isolated DNA 
purity was quantified by NanoDrop ND-1000® 
(Thermo Fisher Scientific Inc., Waltham, MA, 
USA) spectrophotometry and then well-purified 
ones kept at - 20 °C before further use.  
 
Real Time PCR assay 
A SYBR Green Real-time PCR assay was per-
formed for detection of JCV genome presence in 
each sample. The Rotor-Gene-Q 6000 thermocy-
cler (Corbett, Australia) was used for the Real-
time PCR assay. Specific forward 5'-TGA GGA 
ATG CAT GCA GAT CTA C-3' and reverse 5'-
TTT GCA GGG CAT TTT GTT TTT TAC-3' 
primers were used from previous work (6). In 
addition, reaction specificity was achieved by 
melting curve analysis based on previous study. 
To improve the accuracy of the analysis, samples 
were duplicated. About 15 µl reaction mix was 
composed of 7.5µl SYBR RT-PCR Master Mix 
(Odense M, Denmark) was corresponded to 1X 
concentration in each tube, 0.5 µl of each for-
ward and reverse primers (10 pmol/µl), 0.2–0.5 
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μM concentration of each samples or controls, 
and distilled water added for the rest of the total 
volume. Cycling program and temperature were 
as following: 1 cycle of 95 °C for 5 min, 40 cycle 
of 95 °C for 30 sec and 60 °C for 30 sec (fluores-
cent acquisition was performed at the end of this 
step). Melting curve was adjusted for 50 to 99 °C 
by 5 sec Intervals. Positive control was cloned at 
pTZ57R/T plasmid by Generay Biotechnology 
(Generay Biotechnology Co, Shanghai, China). 
 
Statistics  
SPSS 16 software (Chicago, IL, USA) used for 
data analysis. Qualitative variables analyzed by 
Chi-square or Fisher test. P-value <0.05 was con-
sidered statistically significant.  
 
Results 
 
Study population 
All samples were tested for JCV by a Real-time 
PCR assay. Of 157 specimens 66 were CRC cases 
by the mean age (y) ± std. deviation 59.35±14.48 
and 91 healthy control by the mean age (y) ± std. 
deviation 57.21±14.66. Table 1 summarized de-
mographic and pathologic characteristics of each 
groups. 
 
Table 1: Demographic and pathologic characteristics of our study population (n=157) 
 
Category of 
variables 
Variables Male (%) Female (%) Total (%) 
  Case Control Case Control Case Control 
Descriptive No. 38 (57.6) 52 (57.1) 28 (42.4) 39 (42.9) 66 (100) 91 (100) 
Mean age 59.13 56.50 59.64 58.15 59.35 57.21 
Std. Deviation 14.601 15.624 14.589 13.412 14.486 14.661 
Std. Error of 
Mean 
2.369 2.167 2.757 2.148 1.783 1.537 
Range 27-81 15-89 28-85 26-81 27-85 15-89 
Sample loca-
tion 
Colon 15 (39.5) 15 (28.8) 14 (50.0) 14 (35.9) 29 (43.9) 29 (31.9) 
Rectum 10 (26.3) 16 (30.8) 3 (10.7) 9 (23.1) 13 (19.7) 25 (27.5) 
Cecum 7 (18.4) 5 (9.6) 4 (14.3) 11 (28.2) 11 (16.7) 16 (17.6) 
Ileum 1 (2.6) 4 (7.7) 1 (3.6) 1 (2.6) 2 (3.0) 5 (5.5) 
Sigmoid 5 (13.2) 12 (23.1) 6 (21.4) 4 (10.3) 11 (16.7) 16 (17.6) 
Differentiation  Well 21 (55.3) - 15 (55.6) - 36 (55.4) - 
Moderate 13 (34.2) - 8 (29.6) - 21 (32.3) - 
Poorly 1 (2.6) - - - 1 (1.5) - 
Undifferentiated 3 (7.9) - 4 (14.8) - 7 (10.8) - 
Lymph node 
involvement 
Involved 10 (26.3) - 9 (32.1) - 19 (28.8) - 
Not involved 28 (73.7) - 19 (67.9) - 47 (71.2) - 
Tumor stage T1 4 (10.5) - 2 (7.1) - 6 (9.1) - 
T2 6 (15.8) - 3 (10.7) - 9 (13.6) - 
T3 18 (47.4) - 18 (64.3) - 36 (54.5) - 
T4 10 (26.3) - 5 (17.9) - 15 (22.7) - 
Mucinous  Mucinous 14 (36.8) - 6 (9.1) - 20 (30.3) - 
Non-mucinous 24 (63.2) - 22 (33.3) - 46 (69.7) - 
Tumor grade  High grade 16 (42.1) - 11 (16.7) - 27 (40.9) - 
Low grade 22 (57.9) - 17 (25.8) - 39 (59.1) - 
Total   90(57.3) 67(42.7) 157 (100) 
 
Real-Time PCR assay  
Real-time PCR assay performed for all specimens 
for detection of JCV T-Large Ag gene by specific 
primers. Although melting curve analysis showed 
reasonable curve without non-specific products 
(Fig. 1), from all of 157 specimens there was not 
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any positive result and we found that all 157 
specimens were negative for JCV genome infec-
tion.  
 
 
Fig. 1: Melting curve analysis and cycling curve for duplicate positive controls 
 
Statistics 
Analysis of different demographic and pathologic 
variables showed majority of them were not any 
significant result, although CRC more occurred 
in males. However, rectum location and mucin-
ous type of CRC in males were statistically signif-
icant (P<0.05). 
 
Discussion  
 
JCV initial infection occurs in tonsils and diges-
tive tract (6). In some studies, the JCV virus ge-
nome was found in sewage and environmental 
samples. The virus can be transmitted through 
the fecal-oral routs (13, 14). There were some 
reports that showed JCV potential roles in car-
cinogenesis but there are not strong association 
in JCV infection and human cancers. Further-
more, studies on JCV oncogenesis have been re-
stricted to central nervous system (CNS) and rare 
studies in CRC patient’s tissue and compare them 
with the disease-free control tissue was done car-
ried on (7). There was no study on the prevalence 
of JCV infection in gastrointestinal cancer in Iran 
(3). Indeed, the aim of this study was to evaluate 
the infection rate of JCV genome in the CRC pa-
tients against healthy control subjects. By the pre-
sent study results, based on the Real-Time PCR 
data, none of 157 samples was infected with JCV 
genome. JCV prevalence in patients with CRC 
involvement and healthy individuals is low.  
In a study, no association was found between 
JCV and CRC although the authors used CRC 
cases and non-cancerous healthy tissue. Overall, 
233 CRC cases were used and 233 healthy con-
trol tissue but only one from control group was 
positive for JCV genome infection by PCR 
method (15). JCV had not linked to CRC, previ-
ous studies could get positive results due to the 
ubiquity of JCV and probable contaminations, 
and JCV was not causing of genetic instability in 
CRC. Moreover, a study (16) on 386 CRC males 
cases and 386 matched controls, that had high 
seropositivity rate (97%-100%), showed there 
was not any significant association between JCV 
genome infection and CRC by PCR method in 
their tissue samples (OR, 0.9; 95% CI, 0.7-1.3). 
Probably PCR method probably had not enough 
specificity to detect JCV in colonic tissue. Our 
result was same as these findings that showed the 
prevalence of JCV infection in our population is 
very low or the probable low specificity of our 
molecular method that we used. 
In a study, 19 tissue samples of patients with 
CRC lesion were studied and 10 healthy control 
groups using nested-PCR method (11). The au-
thors identified 21% (4/19) JC virus infection in 
cases tissue and no positive result in control 
group tissue. Of 4 JCV positive patients 3 (75%) 
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had liver metastases. JCV could have broader role 
in CRC involvement than we thought before and 
in the end stages of these tumors it has crucial 
roles. We found the same rate of infection by 
JCV in the control healthy subjects although 
there was a great difference in our cases infection 
rates. This discriminate difference was probably 
due to the study group of that study cases. They 
used HCV positive CRC cases that are in higher 
risk for viral infections due to their immunocom-
promised situation.  
Burnett-Hartman et al (7) reviewed five studies in 
order to investigate relationship between colorec-
tal cancer and presence of DNA genome of JC 
virus. They reported presence of genome of this 
virus in patients with CRC as 26 to 89 percent. 
Study on 27 well-characterized epithelial malig-
nant tumors of the large intestine showed there 
were 22 (81%) JCV presence of the viral early 
genome (17). Study in CRC, adenomas and nor-
mal tissue samples by nested PCR for T antigen, 
VP and agnoprotein, showed T antigen was de-
tected in 26.1% (6/23), 4.8% (1/21) and 0% 
(0/20), respectively (18). However, they could 
not find any positive results by VP and agnopro-
tein nested PCR settings. Their findings showed 
T antigen integration in colonic tissue without 
clear and diffuse protein expression could act in 
oncogenesis process and might use for the hit-
and-run mechanism.  
Findings of the current study showed that there 
was no relationship between CRC and infection 
with JCV genome. Of course, it may be due to low 
prevalence of the virus in our population or low 
viral titer in the samples subjected to current study.  
There were some limitations in the current study 
that they included lack of using other confirmato-
ry test such as TaqMan qRT-PCR or nested PCR, 
loss of high quality of genomic DNA by some 
unexpected thawing the extracted samples, using 
one section of each blocks that could reduce our 
chance to find the viral infection and lack of us-
ing ELISA method for detection of anti-JCV Ab 
in patient’s sera. Further studies by broader sub-
jects and using sera anti-JCV Ab results with at 
least on confirmatory test and using several dis-
sections of one patient are recommended.  
 
Conclusion 
 
Although there were some evidence of transfor-
mation capacity of JCV and high prevalence of 
JCV genome in colorectal cancer patients, our 
finding declares there was not any relationship 
between colorectal cancer and JCV infection in 
Iranian subjects and we had not any JCV infec-
tion in large intestine tissue of healthy non-
malignant lesions. Further studies suggested for 
more comprehensive results.  
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